N. Anthony Coles, CEO and Chairperson: Cerevel Therapeutics Holdings CERE Sell · Filed 23/02/08

Trade details

Type: Insider sale
Amount: $1,389,596.32
Shares · price: 42,058 sh · $33.04 a share
Held after: 10,646 sh
Stock: Cerevel Therapeutics Holdings CERE
Person: N. Anthony ColesCEO and Chairperson
Trade date: 23/02/07
Filed: 23/02/08
Days to filing: 1 days

Sold 79.8% of holdings

Share of holding sold: 79.8%

Cerevel Therapeutics Holdings trades, last 26 weeks

What else happened in Cerevel Therapeutics Holdings around then

Filed or reported within 30 days of the trade day · 23/01/08~23/03/09

N. Anthony Coles's recent trades

N. Anthony ColesDirector
Sell10b5-1 planCerevel Therapeutics Holdings
Sell10b5-1 plan
Cerevel Therapeutics Holdings
CERE
$1M
25,000 sh
$1M
Filed 24/07/03
Traded 24/07/01
N. Anthony ColesDirector
Sell10b5-1 planCerevel Therapeutics Holdings
Sell10b5-1 plan
Cerevel Therapeutics Holdings
CERE
$2M
50,000 sh
$2M
Filed 24/06/05
Traded 24/06/03
N. Anthony ColesDirector
Sell10b5-1 planCerevel Therapeutics Holdings
Sell10b5-1 plan
Cerevel Therapeutics Holdings
CERE
$2.1M
50,000 sh
$2.1M
Filed 24/05/14
Traded 24/05/10
N. Anthony ColesDirector
Sell10b5-1 planCerevel Therapeutics Holdings
Sell10b5-1 plan
Cerevel Therapeutics Holdings
CERE
$2.1M
50,000 sh
$2.1M
Filed 24/04/03
Traded 24/04/01
N. Anthony ColesDirector
Sell10b5-1 planCerevel Therapeutics Holdings
Sell10b5-1 plan
Cerevel Therapeutics Holdings
CERE
$2.1M
50,000 sh
$2.1M
Filed 24/03/06
Traded 24/03/04

N. Anthony Coles, Chairman — sold $1.4M of Cerevel Therapeutics Holdings CERE · 79.8% of holdings | Whalegun